G. Aydin, B. Temelli, C. Unaleroglu
FULL PAPER
ppm. 13C NMR (100 MHz, CDCl3): δ = 21.5, 44.0, 55.2, 107.3,
107.3, 108.4, 108.6, 117.3, 127.0, 127.1, 128.3, 128.5, 128.6, 128.7,
129.5, 129.5, 132.3, 133.7, 134.2, 136.9, 137.1, 141.8, 143.6 ppm.
[8.60 (br. s, 1 H)] ppm. 13C NMR (100 MHz, CDCl3): δ = 21.5*,
43.9*, 55.2*, 107.3*, 107.5*, 108.4*, 108.9*, 117.3*, 123.3*, 126.9*,
127.0*, 128.2*, 128.3*, 128.5*, 129.5*, 132.3*, 134.8*, 136.9*,
HRMS (ESI): calcd. for C29H25ClN3O2S [M – H]– 514.1361; found 141.9*, 143.7*, 145.9*, 147.2* ppm. HRMS (ESI): calcd. for
514.1364.
C29H25N4O4S [M – H]– 525.1602; found 525.1636.
General Procedure for the Synthesis of Tripyrranes 4a–4g: Dipyrro-
methanesulfonamide 3 (0.25 mmol) was dissolved in excess pyrrole
(10 mmol). Cu(OTf)2 (0.025 mmol) was added to the reaction mix-
ture at the temperature indicated in Table 4. The reaction was mon-
itored by TLC. After completion of the reaction, the mixture was
passed through a short column packed with silica gel and eluted
with ethyl acetate to remove Cu(OTf)2. The eluent was evaporated
under reduced pressure. The crude product was purified by flash
column chromatography with silica gel 60 (230–400 mesh; ethyl
acetate/hexane, 1:6).
N-[(4-Bromophenyl){5-[phenyl(1H-pyrrol-2-yl)methyl]-1H-pyrrol-2-
yl}methyl]-4-methylbenzenesulfonamide (3d): Brown viscous oil
(63 % yield). R = 0.43 (EtOAc/hexane, 1:3). IR (ATR): ν
=
˜
f
max
3370, 3255, 2925, 1664, 1597, 1487, 1322, 1156, 1097, 1069, 1030,
1010, 908, 810, 770 cm–1. 1H NMR (400 MHz, CDCl3): δ = 2.39
(s, 3 H), 5.12 (d, J = 7.2 Hz, 1 H), 5.34 (s, 1 H), 5.44 (d, J = 7.2 Hz,
1 H), 5.49 (br. s, 1 H), 5.66–5.69 (m, 1 H), 5.86 (br. s, 1 H), 6.14
(br. s, 1 H), 6.67 (br. s, 1 H), 6.97 (d, J = 8.3 Hz, 2 H), 7.11–7.18
(m, 5 H), 7.23–7.33 (m, 4 H), 7.51 (d, J = 8.0 Hz, 2 H), 7.90 (br.
s, 1 H), 8.14 (br. s, 1 H) ppm. 13C NMR (100 MHz, CDCl3): δ =
21.5, 44.0, 55.3, 107.3, 107.4, 108.4, 108.6, 117.3, 121.9, 127.1,
128.3, 128.7, 129.0, 129.4, 129.6, 131.5, 132.1, 134.1, 136.9, 137.5,
141.7, 143.7 ppm. HRMS (ESI): calcd. for C29H25BrN3O2S [M –
H]– 558.0856; found 558.0811.
2-(Phenyl{5-[phenyl(1H-pyrrol-2-yl)methyl]-1H-pyrrol-2-yl}methyl)-
1H-pyrrole (4a):[4g] Black viscous oil (52 % yield). Rf = 0.63
(EtOAc/hexane, 1:3). IR (ATR): ν
= 3362, 3059, 3023, 2925,
˜
max
1698, 1450, 1247, 1028, 963, 884, 767, 717, 698 cm–1. 1H NMR
(400 MHz, CDCl3): δ = 5.17 (br. s, 2 H), 5.60–5.63 (m, 2 H), 5.72
(br. s, 2 H), 5.97 (br. s, 2 H), 6.46 (br. s, 2 H), 7.02–7.06 (m, 4 H),
7.08–7.20 (m, 6 H), 7.54 (br. s, 1 H), 7.64 (br. s, 2 H) ppm. 13C
NMR (100 MHz, CDCl3): δ = 44.0, 107.3, 107.6, 108.6, 117.1,
126.9, 128.4, 128.6, 132.3, 132.4, 142.2 ppm. HRMS (ESI): calcd.
for C26H22N3 [M – H]– 376.1819; found 376.1850.
N-[(4-Methoxyphenyl){5-[phenyl(1H-pyrrol-2-yl)methyl]-1H-pyrrol-
2-yl}methyl]-4-methylbenzenesulfonamide (3e): Brown viscous oil
(45% yield). dr = 52:48. Rf = 0.33 (EtOAc/hexane, 1:3). IR (ATR):
ν
= 3350, 3251, 2917, 1708, 1598, 1511, 1452, 1259, 1160, 1089,
˜
max
1
1034, 817 cm–1. H NMR (400 MHz, CDCl3): δ = 2.34 (s, 6 H)*,
3.71 (s, 6 H)*, 5.27 (br. s, 1 H), [5.30 (s, 1 H)], 5.38 (d, J = 7.2 Hz,
2 H)*, 5.43–5.47 (m, 2 H)*, 5.57–5.61 (m, 4 H)*, 5.78 (br. s, 1 H),
[5.79 (br. s, 1 H)], 6.00–6.05 (m, 2 H)*, [6.52 (br. s, 1 H)], 6.54 (br.
s, 1 H), 6.62 (d, J = 8.4 Hz, 4 H)*, 6.95 (d, J = 8.4 Hz, 4 H)*, 7.05
(d, J = 8.0 Hz, 4 H)*, 7.12 (d, J = 8.0 Hz, 4 H)*, 7.20–7.28 (m, 6
H)*, 7.47 (d, J = 8.0 Hz, 4 H)*, 8.01 (br. s, 2 H)*, 8.40 (br. s, 1 H),
[8.45 (br. s, 1 H)] ppm. 13C NMR (100 MHz, CDCl3): δ = 21.4*,
43.8*, 54.9*, 55.2*, [107.0], 107.1, 107.1*, [108.1], 108.1, 108.2,
[108.2], 113.5*, 116.9, [117.0], 126.4*, 126.6*, 127.0*, [128.2], 128.3,
128.3*, 129.2*, 129.4*, 130.2, [130.2], 130.8, [130.8], 132.2*, [133.5],
133.6, 137.2, [137.3], 142.0*, 158.9* ppm. HRMS (ESI): calcd. for
C30H28N3O3S [M – H]– 510.1857; found 510.1858.
2-[(4-Fluorophenyl){5-[phenyl(1H-pyrrol-2-yl)methyl]-1H-pyrrol-2-
yl}methyl]-1H-pyrrole (4b): Black viscous oil (55% yield). Rf = 0.44
(EtOAc/hexane, 1:3). IR (ATR): ν
= 3366, 3106, 3023, 2921,
˜
max
1712, 1507, 1219, 1026, 849, 774, 731, 695 cm–1 1H NMR
.
(400 MHz, CDCl3): δ = 5.17 (s, 1 H), 5.19 (s, 1 H), 5.53 (br. s, 1
H), 5.56 (br. s, 1 H), 5.64 (br. s, 1 H), 5.67 (br. s, 1 H), 5.92 (br. s,
2 H), 6.47 (br. s, 2 H), 6.80 (t, J = 8.1 Hz, 2 H), 6.93–7.02 (m, 4
H), 7.03–7.15 (m, 3 H), 7.49 (br. s, 1 H), 7.66 (br. s, 2 H) ppm. 13C
NMR (100 MHz, CDCl3): δ = 43.3, 44.1, 107.3, 107.3, 107.6, 108.6,
2
108.7, 115.3 (d, JC,F = 21.2 Hz), 117.0, 117.1, 127.0, 128.3, 128.6,
3
129.8 (d, JC,F = 7.8 Hz), 132.0, 132.0, 132.1, 132.4, 137.8, 142.0,
2
161.8 (d, JC,F = 244.8 Hz) ppm. HRMS (ESI): calcd. for
N-[(4-Cyanophenyl){5-[phenyl(1H-pyrrol-2-yl)methyl]-1H-pyrrol-2-
yl}methyl]-4-methylbenzenesulfonamide (3f): Brown viscous oil
(68% yield). dr = 69:31. Rf = 0.21 (EtOAc/hexane, 1:3). IR (ATR):
C26H21FN3 [M – H]– 394.1725; found 394.1754.
2-[(4-Chlorophenyl){5-[phenyl(1H-pyrrol-2-yl)methyl]-1H-pyrrol-2-
yl}methyl]-1H-pyrrole (4c): Black viscous oil (80% yield). Rf = 0.50
ν
= 3366, 3261, 2923, 2228, 1705, 1560, 1494, 1429, 1323, 1155,
˜
max
1091, 1030, 919, 856, 812, 771, 725 cm–1 1H NMR (400 MHz,
.
(EtOAc/hexane, 1:3). IR (ATR): ν
= 3370, 3094, 2929, 1704,
˜
max
1483, 1176, 1081, 967, 884, 762, 719, 697 cm–1 1H NMR
.
CDCl3): δ = 2.36 (s, 6 H)*, 5.25 (s, 1 H), [5.29 (s, 1 H)], 5.37–5.40
(m, 2 H)*, 5.48–5.54 (m, 2 H)*, 5.60 (br. s, 2 H)*, 5.74–5.83 (m, 3
H)*, 5.91 (d, J = 8.2 Hz, 1 H), 5.99–6.03 (m, 2 H)*, [6.45 (br. s, 1
H)], 6.50 (br. s, 1 H), 7.03–7.11 (m, 8 H)*, 7.15–7.24 (m, 10 H)*,
7.36 (d, J = 8.2 Hz, 4 H)*, 7.40–7.45 (m, 4 H)*, 7.95 (br. s, 2 H)*,
8.43 (br. s, 1 H), [8.53 (br. s, 1 H)] ppm. 13C NMR (100 MHz,
CDCl3): δ = 21.5*, 43.9*, 55.4*, [107.3], 107.4, 107.5*, [108.4],
108.4, 108.9*, 111.6*, 117.3, [117.4], 118.1*, [126.9], 127.0, 128.1*,
128.3*, 128.3*, 128.4*, 128.5*, 129.5*, 131.9*, 132.2*, [134.6],
134.6, [137.0], 137.0, [141.8], 141.9, 143.7*, 144.0* ppm. HRMS
(ESI): calcd. for C30H25N4O2S [M – H]– 505.1704; found 505.1785.
(400 MHz, CDCl3): δ = 5.25–5.32 (m, 2 H), 5.63–5.67 (m, 2 H),
5.77 (br. s, 2 H), 6.04–6.07 (m, 2 H), 6.62 (br. s, 2 H), 7.00–7.24
(m, 9 H), 7.70 (br. s, 1 H), 7.86 (br. s, 2 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 43.5, 44.1, 107.2, 107.3, 107.5, 107.6, 108.4,
108.5, 117.2, 117.4, 127.0, 128.3, 128.6, 128.7, 129.7, 131.8, 132.0,
132.4, 132.6, 132.7, 140.6, 141.9 ppm. HRMS (ESI): calcd. for
C26H21ClN3 [M – H]– 410.1429; found 410.1447.
2-[(4-Bromophenyl){5-[phenyl(1H-pyrrol-2-yl)methyl]-1H-pyrrol-2-
yl}methyl]-1H-pyrrole (4d):[7] Black viscous oil (70% yield). Rf =
0.49 (EtOAc/hexane, 1:3). IR (ATR): ν
= 3468, 2929, 1715,
˜
max
4-Methyl-N-[(4-nitrophenyl){5-[phenyl(1H-pyrrol-2-yl)methyl]-1H- 1499, 1101, 1042, 1014, 904, 727, 648 cm–1. 1H NMR (400 MHz,
pyrrol-2-yl}methyl]benzenesulfonamide (3g): Brown viscous oil (70%
yield). dr = 63:37. R = 0.26 (EtOAc/hexane, 1:3). IR (ATR): ν
CDCl3): δ = 5.26 (br. s, 1 H), 5.30 (br. s, 1 H), 5.63–5.70 (m, 2 H),
5.75–5.81 (m, 2 H), 6.03–6.10 (m, 2 H), 6.61 (br. s, 2 H), 6.98 (d,
J = 8.3 Hz, 2 H), 7.11 (d, J = 7.4 Hz, 2 H), 7.16–7.22 (m, 1 H),
7.23 (d, J = 7.4 Hz, 2 H), 7.34 (d, J = 8.3 Hz, 2 H), 7.68 (br. s, 1
˜
f
max
= 3363, 2961, 2924, 1705, 1519, 1493, 1346, 1259, 1155, 1090, 1030,
862, 793, 725 cm–1. 1H NMR (400 MHz, CDCl3): δ = 2.32 (s, 6
H)*, 5.27 (s, 1 H), [5.29 (s, 1 H)], 5.39 (br. s, 2 H)*, 5.56 (br. s, 2 H), 7.84 (br. s, 2 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 43.5,
H)*, 5.60 (br. s, 4 H)*, 5.77 (br. s, 2 H)*, 6.01 (br. s, 2 H)*, [6.49 44.0, 107.2, 107.3, 107.5, 107.6, 108.4, 108.5, 117.3, 117.4, 120.8,
(br. s, 1 H)], 6.52 (br. s, 1 H), 7.03 (d, J = 7.8 Hz, 4 H)*, 7.08 (d, 127.0, 128.3, 128.7, 130.1, 131.6, 131.9, 132.4, 132.7, 141.1,
J = 7.8 Hz, 4 H)*, 7.18–7.26 (m, 10 H)*, 7.44 (d, J = 7.8 Hz, 4 141.9 ppm. HRMS (ESI): calcd. for C26H21BrN3 [M – H]–
H)*, 7.91 (d, J = 7.8 Hz, 4 H)*, 8.03 (br. s, 2 H)*, 8.57 (br. s, 1 H),
454.0924; found 454.0940.
7590
www.eurjoc.org
© 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2015, 7583–7593